141 related articles for article (PubMed ID: 17895370)
1. The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway.
Llamazares M; Obaya AJ; Moncada-Pazos A; Heljasvaara R; Espada J; López-Otín C; Cal S
J Cell Sci; 2007 Oct; 120(Pt 20):3544-52. PubMed ID: 17895370
[TBL] [Abstract][Full Text] [Related]
2. Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis.
El Hour M; Moncada-Pazos A; Blacher S; Masset A; Cal S; Berndt S; Detilleux J; Host L; Obaya AJ; Maillard C; Foidart JM; Ectors F; Noel A; Lopez-Otin C
Oncogene; 2010 May; 29(20):3025-32. PubMed ID: 20208563
[TBL] [Abstract][Full Text] [Related]
3. The roles of ADAMTS in angiogenesis and cancer.
Sun Y; Huang J; Yang Z
Tumour Biol; 2015 Jun; 36(6):4039-51. PubMed ID: 25916206
[TBL] [Abstract][Full Text] [Related]
4. ADAMTS12 promotes oxaliplatin chemoresistance and angiogenesis in gastric cancer through VEGF upregulation.
Jiang Y; Huang J; Huang Z; Li W; Tan R; Li T; Chen Z; Tang X; Zhao Y; Qiu J; Li C; Chen H; Yang Z
Cell Signal; 2023 Nov; 111():110866. PubMed ID: 37619822
[TBL] [Abstract][Full Text] [Related]
5. The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways.
Kim CK; Choi YK; Lee H; Ha KS; Won MH; Kwon YG; Kim YM
Mol Pharmacol; 2010 Jul; 78(1):142-50. PubMed ID: 20406854
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells.
Sulpice E; Ding S; Muscatelli-Groux B; Bergé M; Han ZC; Plouet J; Tobelem G; Merkulova-Rainon T
Biol Cell; 2009 Sep; 101(9):525-39. PubMed ID: 19281453
[TBL] [Abstract][Full Text] [Related]
7. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
Fan S; Meng Q; Laterra JJ; Rosen EM
Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
9. Novel MAPK-dependent and -independent tubulogenes identified via microarray analysis of 3D-cultured Madin-Darby canine kidney cells.
Chacon-Heszele MF; Zuo X; Hellman NE; McKenna S; Choi SY; Huang L; Tobias JW; Park KM; Lipschutz JH
Am J Physiol Renal Physiol; 2014 May; 306(9):F1047-58. PubMed ID: 24573390
[TBL] [Abstract][Full Text] [Related]
10. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
[TBL] [Abstract][Full Text] [Related]
11. The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer.
Moncada-Pazos A; Obaya AJ; Fraga MF; Viloria CG; Capellá G; Gausachs M; Esteller M; López-Otín C; Cal S
J Cell Sci; 2009 Aug; 122(Pt 16):2906-13. PubMed ID: 19638407
[TBL] [Abstract][Full Text] [Related]
12. Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering.
Tanimura S; Chatani Y; Hoshino R; Sato M; Watanabe S; Kataoka T; Nakamura T; Kohno M
Oncogene; 1998 Jul; 17(1):57-65. PubMed ID: 9671314
[TBL] [Abstract][Full Text] [Related]
13. Neurocan is a New Substrate for the ADAMTS12 Metalloprotease: Potential Implications in Neuropathies.
Fontanil T; Mohamedi Y; Moncada-Pazos A; Cobo T; Vega JA; Cobo JL; García-Suárez O; Cobo J; Obaya ÁJ; Cal S
Cell Physiol Biochem; 2019; 52(5):1003-1016. PubMed ID: 30977985
[TBL] [Abstract][Full Text] [Related]
14. ADAMTS5 functions as an anti-angiogenic and anti-tumorigenic protein independent of its proteoglycanase activity.
Kumar S; Sharghi-Namini S; Rao N; Ge R
Am J Pathol; 2012 Sep; 181(3):1056-68. PubMed ID: 22796434
[TBL] [Abstract][Full Text] [Related]
15. Constitutively active mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells.
Montesano R; Soriano JV; Hosseini G; Pepper MS; Schramek H
Cell Growth Differ; 1999 May; 10(5):317-32. PubMed ID: 10359013
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo.
Rocks N; Paulissen G; Quesada-Calvo F; Munaut C; Gonzalez ML; Gueders M; Hacha J; Gilles C; Foidart JM; Noel A; Cataldo DD
Cancer Res; 2008 Nov; 68(22):9541-50. PubMed ID: 19010931
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
18. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.
Iglesias M; Frontelo P; Gamallo C; Quintanilla M
Oncogene; 2000 Aug; 19(36):4134-45. PubMed ID: 10962574
[TBL] [Abstract][Full Text] [Related]
19. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A
Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma.
Tsubaki M; Yamazoe Y; Yanae M; Satou T; Itoh T; Kaneko J; Kidera Y; Moriyama K; Nishida S
Cytokine; 2011 Apr; 54(1):100-7. PubMed ID: 21292498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
